Aspen Pharmacare's market cap is currently $2.60B. The company's EPS TTM is $-0.425; its P/E ratio is 10.58; and it has a dividend yield of 2.06%. Aspen Pharmacare is scheduled to report earnings on September 3, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
